Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cells

被引:7
|
作者
Page, G [1 ]
Chalon, S
Emond, P
Maloteaux, JM
Hermans, E
机构
[1] Catholic Univ Louvain, Lab Pharmacol expt, FARL, B-1200 Brussels, Belgium
[2] Fac Med & Pharm, UPRESEA 1223, GEMCI, F-86005 Poitiers, France
[3] INSERM, Lab Biophys Med & Pharmaceut, F-38200 Tours, France
关键词
neuronal dopamine transporter; DA uptake; PE2I; GBR; 12935; COS cells; selective inhibitor;
D O I
10.1016/S0197-0186(01)00086-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interaction of (E)-N-(3-iodoprop-2-enyl)-2beta-Carbomethoxy-3beta-(4'-methylphenyl) nortropane (PE2I) with the rat neuronal dopamine transporter (DAT) was studied in transfected COS cells by measuring its ability to inhibit DA uptake and by measuring its affinity in radioligand binding experiments. Saturable [H-3]DA uptake was measured in COS cells transiently transfected with the cDNA sequence encoding the rat DAT. Pharmacological characterisation of this uptake revealed functional properties with a V-max,a value of 45.05 +/- 2.62 pmol/mg protein per min and a K-m value of 2.86 +/- 0.28 muM. The specific [H-3]DA uptake was fully inhibited by 1 muM PE2I. Concentration response curves revealed the high potency of PE2I in inhibiting DA uptake (pEC(50) value of 8.70 +/- 0.33), 25 times higher than that observed for the reference DAT inhibitor, GBR 12935. On crude homogenates from transfected COS cells, PE2I displaced the specific binding of [3 H]GBR 12935 with a PKi value of 7.73 +/- 0.13. Accordingly, [I-125]PE2I was found to specifically recognise a single binding site population which is almost completely displaced by GBR 12935 and nomifensine. Saturation experiments revealed the high affinity of [I-125]PE2I (K-D value of 3.8 +/- 0.63 nM) that correlates with the high potency of PEN in inhibiting the [H-3]DA uptake. This contrasts with the results obtained with GBR 12935 for which a discrepancy was found between its high affinity in binding assays (KD value of 0.43 +/- 0.04 nM) and its rather low potency in functional assays (pEC50 value of 7.30 +/- 0.05). A relatively high level of [H-3]GBR 12935 binding was detected in non transfected COS cells. Such nomifensine resistant binding is attributed to the interaction of GBR 12935 with cytochrome P-450 as it was displaced by cis-(Z)-flupentixol (an inhibitor of cytochrome P-450). Such interaction was not observed using PE2I. Taken together, these data demonstrate that PE2I was a highly potent inhibitor of cloned DAT compared with GBR 12935 and provided a useful tool for further investigations in cells transfected with cDNA encoding the DAT. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:105 / 113
页数:9
相关论文
共 46 条
  • [21] Development of a new dopamine transporter(DAT)imaging agent [18f]N-3-fluoropropyl-2-B-carbomethoxy-3-(4/methylphenyl) nortropane(18FFPCMT).
    Chaly, TC
    Matacchieri, RA
    Dahl, JR
    Dhawan, V
    Eidelberg, D
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 305P - 305P
  • [22] COMPARISON OF I-123 LABELED 2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)TROPANE AND 2-BETA-CARBOMETHOXY-3-BETA-(4-IODOPHENYL)-N-(3-FLUOROPROPYL)NORTROPANE FOR IMAGING OF THE DOPAMINE TRANSPORTER IN THE LIVING HUMAN BRAIN
    KUIKKA, JT
    BERGSTROM, KA
    AHONEN, A
    HILTUNEN, J
    HAUKKA, J
    LANSIMIES, E
    WANG, SY
    NEUMEYER, JL
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1995, 22 (04): : 356 - 360
  • [23] Synthesis of N-(3-[18F]fluoropropyl)-2β-carbomethoxy-3β-(4-iodophenyl)nortropane ([18F]FP-β-CIT)
    Klok, RP
    Klein, PJ
    Herscheid, JDM
    Windhorst, AD
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2006, 49 (02): : 77 - 89
  • [24] One step high yield synthesis of N-(3-[18F] fluoropropyl)-2β-carbomethoxy-3β-(4-iodophenyl) nortropane with protic solvent system
    Lee, S.
    Oh, S.
    Chi, D.
    Kil, H.
    Kim, J.
    Moon, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S174 - S174
  • [25] 2β-carbomethoxy-3β-(4′-chlorophenyl)-8[(E)-[F-18]4-fluorobuten-2-yl]nortropane (FBT):: Synthesis, characterization and primate imaging of a radioligand for mapping dopamine transporter (DAT) sites by PET.
    Chen, P
    Keil, R
    Votaw, JR
    Deterding, T
    Hoffman, JM
    Kilts, C
    Abak, T
    Camp, VM
    Votaw, DB
    Malveaux, E
    Goodman, MM
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 35P - 35P
  • [26] Cationic interactions at the human dopamine transporter reveal binding conformations for dopamine distinguishable from those for the cocaine analog 2α-carbomethoxy-3α-(4-fluorophenyl)tropane
    Chen, NH
    Sun, LL
    Reith, MEA
    JOURNAL OF NEUROCHEMISTRY, 2002, 81 (06) : 1383 - 1393
  • [27] Analysis of 2β-carbomethoxy-3β-(4-fluorophenyl)-N-(3-iodo-E-allyl)nortropane in rat plasma -: II.: Pharmacokinetic profile in male and female Sprague-Dawley rats evaluated by capillary electrophoresis
    Hettiarachchi, K
    Green, CE
    Ramanathan-Girish, S
    Wu, B
    Jackson, CJ
    Ridge, S
    Salem, MA
    Lanser, ME
    JOURNAL OF CHROMATOGRAPHY A, 2001, 924 (1-2) : 471 - 481
  • [28] [123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies
    Walker, Zuzana
    Cummings, Jeffrey L.
    ALZHEIMERS & DEMENTIA, 2012, 8 (01) : 74 - 83
  • [29] Synthesis, Fluorine-18 Radiolabeling, and Biological Evaluation of N-((E)-4-Fluorobut-2-en-1-yl)-2β-carbomethoxy-3β-(4′-halophenyl)nortropanes: Candidate Radioligands for In Vivo Imaging of the Brain Dopamine Transporter with Positron Emission Tomography
    Stehouwer, Jeffrey S.
    Daniel, Lauryn M.
    Chen, Ping
    Voll, Ronald J.
    Williams, Larry
    Plott, Susan J.
    Votaw, John R.
    Owens, Michael J.
    Howell, Leonard
    Goodman, Mark M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (15) : 5549 - 5557
  • [30] Labeling of dopamine transporter transmembrane domain 1 with the tropane ligand N-[4-(4-Azido-3-[125I]iodophenyl)butyl]-2β-carbomethoxy-3β-(4-chlorophenyl)tropane implicates proximity of cocaine and substrate active sites
    Parnas, M. Laura
    Gaffaney, Jon D.
    Zou, Mu Fa
    Lever, John R.
    Newman, Amy Hauck
    Vaughan, Roxanne A.
    MOLECULAR PHARMACOLOGY, 2008, 73 (04) : 1141 - 1150